InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Slilaty Steve N., 首席执行官. Insider active across 1 company, notably Sunshine Biopharma, Inc. In total, 3 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €11k. History available since 18 February 2022. The latest transaction was filed on 4 March 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Steve N. Slilaty is the Chief Executive Officer of Sunshine Biopharma, Inc. In this role, he is responsible for the strategic and operational leadership of the company. Steve brings extensive experience in the biopharmaceutical sector, contributing to innovation and growth at Sunshine Biopharma. His leadership is essential to achieve the company's objectives and ensure its sustainability.